The Funding of Biopharmaceutical Research and Development
  • Release Date : 31 October 2013
  • Publisher : Elsevier
  • Categories : Medical
  • Pages : 284 pages
  • ISBN 13 : 9781908818386
  • ISBN 10 : 1908818387
Score: 4
From 245 Ratings
CLICK HERE TO GET BOOK

Synopsis : The Funding of Biopharmaceutical Research and Development written by David R Williams, published by Elsevier which was released on 31 October 2013. Download The Funding of Biopharmaceutical Research and Development Books now! Available in PDF, EPUB, Mobi Format. The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market. These funding options are continually changing and complex, and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally. This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement. The book also presents an overview of the IPO process and the various fates of firms going public. Presents a comprehensive view of the funding issues of R&D in this market sector, adopting a theory-to-practice approach A comprehensive and analytical review of the biopharmaceutical R&D literature and practice An overview of the various and competing/complementary theories of the firm and valuation methods as they apply to biopharmaceutical R&D

Strategies to Leverage Research Funding

Strategies to Leverage Research Funding

Author : Institute of Medicine,Board on Health Sciences Policy,Medical Follow-Up Agency,Committee on Alternative Funding Strategies for DOD's Peer Reviewed Medical Research Programs
Publisher : National Academies Press
Category : Medical
GET BOOK
Rare Diseases and Orphan Products

Rare Diseases and Orphan Products

Author : Institute of Medicine,Board on Health Sciences Policy,Committee on Accelerating Rare Diseases Research and Orphan Product Development
Publisher : National Academies Press
Category : Medical
GET BOOK